We attend the World Vaccine Congress US
“Enhancing cell-based vaccine production with new animal-free recombinant proteins”. This is the title of our presentation at The World Vaccine Congress, the world’s leading vaccine event, in Washington, D.C., from April 22 to 24. Our Senior Global Product Manager, Marie-Louise Lunn, Ph.D, will give the presentation on Wednesday, April 23, at 12:10. Meet our stellar […]
Novo Nordisk Pharmatech Annual Report 2024
Our purpose – enabling better medicines, enabling better lives has for years centred around our commitment to bring forward pharmaceutical materials that enable our customers to produce better medicines. In 2024, we marked our 75th anniversary, an important milestone in our company’s history. What started as a small chemistry factory in Køge has become a […]
Join us at Biologics Manufacturing Asia
Join us at Biologics Manufacturing Asia, the continent’s #1 bioprocessing event, on March 12-13 in Singapore. It´s the place to discuss biologic innovations that enhance efficiency and productivity. At booth #5 we’ll showcase Recombinant Insulin and our new enzyme TrypsiNNex®, sharing information about how the products can enhance the safety and efficiency of upstream biomanufacturing […]
Live webinar on March 19, 2025
In this webinar, the expert speakers will illustrate how both Recombinant Insulin and TrypsiNNex® significantly enhance the safety and efficiency of upstream biomanufacturing processes, thereby enhancing the overall efficiency of therapeutic biologics production.
Expansion of distribution partnership in Europe
Actylis and Novo Nordisk Pharmatech are expanding their strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
Where to meet us in 2025
Join us at the most important conferences in 2025. Our teams of experts will be there to answer all your questions, especially about our Recombinant Insulin and TrypsiNNex®. We will exhibit at: Biologics Manufacturing Asia at Marina Bay Sands Expo & Convention Centre in Singapore, March 12-13, 2025 World Vaccine Congress US at Walter E […]
Novo Nordisk Pharmatech launches TrypsiNNex®
Today marks an important milestone at Novo Nordisk Pharmatech as we announce the launch of TrypsiNNex® – a new recombinant enzyme in the company portfolio. This product represents a key part of our growth strategy in the specialty enzymes sector for pharmaceutical manufacturing. TrypsiNNex® is a sustainable, animal-free trypsin product that will enable the production […]
We will attend BPI US 2024
We are thrilled to announce our attendance at the upcoming BioProcess International Congress, which will take place September 24-26 at Hynes Convention Center in Boston! We will showcase one of our key specialities, Recombinant Insulin, at booth 814. Approved by the FDA and EMA, our animal-free Insulin is a vital ingredient in over 100 therapeutic […]
Novo Nordisk Pharmatech is investing 1.5 billion Danish kroner in a new factory in Køge
In order to meet significantly higher demand from Novo Nordisk A/S for raw materials for the production of medicines to fight chronic diseases, Novo Nordisk Pharmatech A/S is building a new factory at Ådalen 16 in Køge. In March 2023, Novo Nordisk Pharmatech announced the purchase of a 47,000 m² site in Køge, with the […]
New distribution partnership in Europe
Actylis and Novo Nordisk Pharmatech announce a strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
